Gamma scintigraphy: How should we measure regional lung deposition?

M. Biddiscombe, R. Underwood, S. Meah, O. Usmani (London, United Kingdom)

Source: Annual Congress 2010 - State of the art imaging
Session: State of the art imaging
Session type: E-Communication Session
Number: 5279
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

Introduction: Two-dimensional gamma scintigraphy (2DGS) is used for quantifying the amount of drug delivered from therapeutic inhaler devices to the lungs. The lungs are divided into central (C) intermediate (I) and peripheral (P) regions. Aim: To compare 4 methods of partitioning the lung image. Methods: Using lung deposition data for 4 mild asthmatics we calculated the P/C ratio and Penetration Index (PI). PI = P/C count rate for aerosol deposition divided by P/C count rate for a krypton-ventilation scan. Results: (Table) The lung areas of C and P regions and gamma count rate varied greatly depending on the method used but there was good agreement of PI. Conclusions: PI is least affected by how lung regions are drawn and should be the primary endpoint to compare results from different scintigraphic lung deposition studies. Care should be taken when attributing 2DGS regions to specific 3D-anatomical airway structures.

MethodP/CPIRegion Area %Region Count Rate %
   CPCP
10.70.419.752.336.725.5
20.70.532.567.559.740.3
31.40.620.379.741.258.8
40.90.525.674.452.547.5




Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Biddiscombe, R. Underwood, S. Meah, O. Usmani (London, United Kingdom). Gamma scintigraphy: How should we measure regional lung deposition?. Eur Respir J 2010; 36: Suppl. 54, 5279

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison between dual-energy computed tomography and standard lung perfusion scintigraphy in preoperative evaluation of lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013

High-resolution computed tomography fibrosis score and pulmonary function tests in interstitial lung disease: Is there any correlation?
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Ultrasound in the assessment of interstitial lung diseases: Correlation with high-resolution computed tomography and lung functions
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Automated software for the measurement of lung volume: quantitative lung perfusion SPECT
Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology
Year: 2007


Echocardiography in patients evaluated for bronchoscopic lung volume reduction: is it useful and is there a CT-derived alternative?
Source: International Congress 2019 – Thoracic surgery
Year: 2019


Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

A new method for determining lung densities on computed tomography. Study of the correlation between tomography and plethysmography for estimating lung volumes
Source: Eur Respir J 2006; 28: Suppl. 50, 420s
Year: 2006

Simultaneous assessment of metabolism and vascularity of lung cancer using perfusion CT-PET: a feasibility study
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008


Comparison of low-dose CT image registration-based metrics of regional ventilation distribution with global lung function and diffusion capacity in COPD patients
Source: Virtual Congress 2020 – From respiratory physiology to diagnosis and treatment
Year: 2020


Ultra-low dose CT in the assessment of diffuse lung disease: Comparison with conventional images
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


Volumetric capnography: a promising lung function test in cystic fibrosis?
Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults
Year: 2020




The value of lung perfusion scintigraphy in the prediction of postoperative function in lung cancer
Source: Annual Congress 2004 - Assessment of lung function before resection of lung cancer
Year: 2004


Measurement of pulmonary aerosol deposition with combined SPECT-CT
Source: Annual Congress 2010 - State of the art imaging
Year: 2010


Prediction of FEV1 and DLco in lung cancer patients undergoing lobectomy: Comparison between quantitative computed tomography, scintigraphy, and anatomy.
Source: International Congress 2019 – Thoracic surgery
Year: 2019


Preoperative assessment for Lung Volume Reduction for emphysema – is a perfusion scan really necessary ?
Source: International Congress 2019 – General thoracic surgery
Year: 2019

Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
Source: Eur Respir J 2002; 20: Suppl. 38, 186s
Year: 2002

The use of SPECT in preoperative assessment of patients with lung cancer
Source: Eur Respir J 2004; 24: 258-262
Year: 2004



Vibration response imaging [VRI]: a new dynamic system for the regional assessment of lung function
Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future
Year: 2008

Assessing regional lung function in emphysema using a new, vibration response imaging (VRI*) technology
Source: Eur Respir J 2005; 26: Suppl. 49, 315s
Year: 2005